Poradosu Enrique (CIK 0001898147)

Latest company ownership

NVCT - Nuvectis Pharma, Inc.

Role: Chief Science & Business Off

Shares held

1,656,319

Last filed at

Jan 3, 2025

Confidence Score

50.0

2025Q4

Confidence Score History

2022Q1 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Nov 19, 2024	Nov 20, 2024	Nuvectis Pharma, Inc.	Chief Science & Business Off	Buy	55.0	+2,000	0.13%	✗	$10K
May 10, 2024	May 13, 2024	Nuvectis Pharma, Inc.	Chief Science & Business Off	Buy	47.5	+500	0.03%	✗	$3.1K
Mar 27, 2023	Mar 28, 2023	Nuvectis Pharma, Inc.	Chief Science & Business Off	Buy	47.5	+500	0.04%	✗	$5.8K
May 12, 2022	May 16, 2022	Nuvectis Pharma, Inc.	Chief Science & Business Off	Buy	56.3	+670	0.05%	✗	$10.3K
Feb 4, 2022	Feb 8, 2022	Nuvectis Pharma, Inc.	Chief Science & Business Off	Buy	61.3	+4,600	0.39%	✗	$15.8K